Skip to main
  1. Stocks
  2. Telix Pharmaceuticals Ltd
  3. Market Cap
TLX

TLX Market Capitalization Overview

Market Cap: $3.06B as of Oct 26, 2026

$3.06B
$832.20M (21.38%)past month
As of Oct 26, 2026, TLX has a market capitalization of $3.06B. Over the past 30 days, its market cap has decreased by -1.17%, while in the last 12 months, it has increased by 20.58%.

Market capitalization represents the total value of Telix Pharmaceuticals Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

TLX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of TLX helps investors assess the company's size and compare it with competitors for better investment decisions.

TLX Market Cap & Key Trends

See Telix Pharmaceuticals Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in TLX

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TLX Market Cap History

DateMarket CapChange
Oct 1, 2026$3.65B-1.17%
Sep 1, 2026$3.69B+8.28%
Aug 3, 2026$3.41B-15.27%
Jul 1, 2026$4.02B+25.69%
Jun 1, 2026$3.20B-16.28%
May 1, 2026$3.82B+21.94%
Apr 1, 2026$3.14B+31.11%
Mar 2, 2026$2.39B-5.11%
Feb 2, 2026$2.52B-2.49%
Jan 2, 2026$2.59B-22.39%

TLX End of Year Market Cap History

DateMarket CapChange
2026$3.06B+20.58%
2025$2.54B-50.78%
2024$5.16B—

FAQs About Telix Pharmaceuticals Ltd (TLX) Market Cap

As of Oct 26, 2026, the market capitalization of TLX is $3.06B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Telix Pharmaceuticals Ltd’s market capitalization has decreased by -21.38%, changing from $3.90B to $3.06B as of Oct 26, 2026.

In the last 3 months, Telix Pharmaceuticals Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Telix Pharmaceuticals Ltd’s market capitalization decreased from $5.16B in January to $2.54B in December, reflecting a -50.78% change.

In the past five years, TLX has had a compound annual growth rate (CAGR) of -29.84% in market capitalization. This means its market cap has shrunk at an average rate of -29.84% per year.

Telix Pharmaceuticals Ltd (TLX)


TLX Market Cap & Key Trends

See Telix Pharmaceuticals Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in TLX

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TLX stock data and trends